{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T01:42:29Z","timestamp":1792978949252,"version":"4.5.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T00:00:00Z","timestamp":1746403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T00:00:00Z","timestamp":1746403200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Health Commission of Hubei Province scientific research project","award":["No. WJ2021M143"],"award-info":[{"award-number":["No. WJ2021M143"]}]},{"name":"the Health Commission of Hubei Province scientific research project","award":["No. WJ2021M143"],"award-info":[{"award-number":["No. WJ2021M143"]}]},{"name":"the Health Commission of Hubei Province scientific research project","award":["No. WJ2021M143"],"award-info":[{"award-number":["No. WJ2021M143"]}]},{"name":"the Health Commission of Hubei Province scientific research project","award":["No. WJ2021M143"],"award-info":[{"award-number":["No. WJ2021M143"]}]},{"name":"the Health Commission of Hubei Province scientific research project","award":["No. WJ2021M143"],"award-info":[{"award-number":["No. WJ2021M143"]}]},{"name":"The Fundamental Research Funds for the Central Universities","award":["No. 413000714"],"award-info":[{"award-number":["No. 413000714"]}]},{"name":"The Fundamental Research Funds for the Central Universities","award":["No. 413000714"],"award-info":[{"award-number":["No. 413000714"]}]},{"name":"The Fundamental Research Funds for the Central Universities","award":["No. 413000714"],"award-info":[{"award-number":["No. 413000714"]}]},{"name":"The Fundamental Research Funds for the Central Universities","award":["No. 413000714"],"award-info":[{"award-number":["No. 413000714"]}]},{"name":"The Fundamental Research Funds for the Central Universities","award":["No. 413000714"],"award-info":[{"award-number":["No. 413000714"]}]},{"name":"The Research Fund of Anhui Institute of translational medicine","award":["grant number: 2023zhyx-C61"],"award-info":[{"award-number":["grant number: 2023zhyx-C61"]}]},{"name":"The Research Fund of Anhui Institute of translational medicine","award":["grant number: 2023zhyx-C61"],"award-info":[{"award-number":["grant number: 2023zhyx-C61"]}]},{"name":"The Research Fund of Anhui Institute of translational medicine","award":["grant number: 2023zhyx-C61"],"award-info":[{"award-number":["grant number: 2023zhyx-C61"]}]},{"name":"The Research Fund of Anhui Institute of translational medicine","award":["grant number: 2023zhyx-C61"],"award-info":[{"award-number":["grant number: 2023zhyx-C61"]}]},{"name":"The Research Fund of Anhui Institute of translational medicine","award":["grant number: 2023zhyx-C61"],"award-info":[{"award-number":["grant number: 2023zhyx-C61"]}]},{"name":"the Research Fund Project of Anhui Medical University","award":["grant number 2022xkj148"],"award-info":[{"award-number":["grant number 2022xkj148"]}]},{"name":"the Research Fund Project of Anhui Medical University","award":["grant number 2022xkj148"],"award-info":[{"award-number":["grant number 2022xkj148"]}]},{"name":"the Research Fund Project of Anhui Medical University","award":["grant number 2022xkj148"],"award-info":[{"award-number":["grant number 2022xkj148"]}]},{"name":"the Research Fund Project of Anhui Medical University","award":["grant number 2022xkj148"],"award-info":[{"award-number":["grant number 2022xkj148"]}]},{"name":"the Research Fund Project of Anhui Medical University","award":["grant number 2022xkj148"],"award-info":[{"award-number":["grant number 2022xkj148"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-025-03386-y","type":"journal-article","created":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T16:03:37Z","timestamp":1746461017000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Improving epilepsy management by targeting P2\u2009\u00d7\u20097 receptor with ROS\/electric responsive nanomicelles"],"prefix":"10.1186","volume":"23","author":[{"given":"Zhaohong","family":"Kong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huisheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,5]]},"reference":[{"key":"3386_CR1","doi-asserted-by":"publisher","unstructured":"Choi J, Kim SY, Kim H, et al. Serum \u03b1-synuclein and IL-1\u03b2 are increased and correlated with measures of disease severity in children with epilepsy: potential prognostic biomarkers? BMC Neurol. 2020;20(1). https:\/\/doi.org\/10.1186\/s12883-020-01662-y.","DOI":"10.1186\/s12883-020-01662-y"},{"key":"3386_CR2","doi-asserted-by":"publisher","unstructured":"Sabzvari T, Aflahe Iqbal M, Ranganatha A, et al. A comprehensive review of recent trends in surgical approaches for epilepsy management. Cureus Published Online Oct. 2024;17. https:\/\/doi.org\/10.7759\/cureus.71715.","DOI":"10.7759\/cureus.71715"},{"key":"3386_CR3","doi-asserted-by":"publisher","unstructured":"Raslan EE, Al-Hawas SF, Alghamdi MM, et al. Assessment of the efficacy of deep brain stimulation (DBS) in managing Drug-Resistant epilepsy (DRE): A systematic review and Meta-Analysis of randomized controlled trials (RCTs). Cureus. Published Online Oct. 2024;13. https:\/\/doi.org\/10.7759\/cureus.71348.","DOI":"10.7759\/cureus.71348"},{"issue":"12","key":"3386_CR4","doi-asserted-by":"publisher","first-page":"3970","DOI":"10.1093\/brain\/awae338","volume":"147","author":"A Vezzani","year":"2024","unstructured":"Vezzani A. Focal brain administration of Antiseizure medications improves outcomes and reduces side effects. Brain. 2024;147(12):3970\u20132. https:\/\/doi.org\/10.1093\/brain\/awae338.","journal-title":"Brain"},{"key":"3386_CR5","doi-asserted-by":"publisher","unstructured":"Hollis A, Lukens JR. Role of inflammasomes and neuroinflammation in epilepsy. Immunol Rev. 2024;329(1). https:\/\/doi.org\/10.1111\/imr.13421.","DOI":"10.1111\/imr.13421"},{"key":"3386_CR6","doi-asserted-by":"publisher","unstructured":"Liu X, Li Y, Huang L, et al. Unlocking the therapeutic potential of P2X7 receptor: a comprehensive review of its role in neurodegenerative disorders. Front Pharmacol. 2024;15. https:\/\/doi.org\/10.3389\/fphar.2024.1450704.","DOI":"10.3389\/fphar.2024.1450704"},{"key":"3386_CR7","doi-asserted-by":"publisher","unstructured":"Ming Y, Zhao P, Zhang H et al. Complement Molecule C3a Exacerbates Early Brain Injury After Subarachnoid Hemorrhage by Inducing Neuroinflammation Through the C3aR-ERK-P2X7-NLRP3 Inflammasome Signaling Axis. Inflammation. Published online November 11, 2024. https:\/\/doi.org\/10.1007\/s10753-024-02155-7","DOI":"10.1007\/s10753-024-02155-7"},{"key":"3386_CR8","doi-asserted-by":"publisher","unstructured":"Pacheco PAF, Faria RX. Are purinergic receptors overlooked targets in hyperinflammatoryresponses?? CMP. 2024;17. https:\/\/doi.org\/10.2174\/0118761429268892231116044537.","DOI":"10.2174\/0118761429268892231116044537"},{"key":"3386_CR9","doi-asserted-by":"publisher","unstructured":"Jin GN, Wang Y, Liu YM, et al. Arctiin mitigates neuronal injury by modulating the P2X7R\/NLPR3 inflammasome signaling pathway. Inflamm Published Online August. 2024;17. https:\/\/doi.org\/10.1007\/s10753-024-02117-z.","DOI":"10.1007\/s10753-024-02117-z"},{"issue":"3","key":"3386_CR10","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1002\/tox.24021","volume":"39","author":"V Gelen","year":"2023","unstructured":"Gelen V, \u00d6zkanlar S, Kara A, Ye\u015filda\u011f A. Citrate-coated silver nanoparticles loaded with agomelatine provide neuronal therapy in acute cerebral ischemia\/reperfusion of rats by inhibiting the oxidative stress, endoplasmic reticulum stress, and P2X7 receptor\u2010mediated inflammasome. Environ Toxicol. 2023;39(3):1531\u201343. https:\/\/doi.org\/10.1002\/tox.24021.","journal-title":"Environ Toxicol"},{"key":"3386_CR11","doi-asserted-by":"publisher","unstructured":"Fan Z, Wang K, Zhao X, Sun X. P2X7 receptor: A receptor closely linked with sepsis-associated encephalopathy. Open Life Sci. 2024;19(1). https:\/\/doi.org\/10.1515\/biol-2022-0775.","DOI":"10.1515\/biol-2022-0775"},{"issue":"10","key":"3386_CR12","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.3390\/pharmaceutics16101327","volume":"16","author":"H Zhang","year":"2024","unstructured":"Zhang H, Li L, Li W, Yin H, Wang H, Ke X. Endosomal pH, redox Dual-Sensitive prodrug micelles based on hyaluronic acid for intracellular camptothecin delivery and active tumor targeting in Cancer therapy. Pharmaceutics. 2024;16(10):1327. https:\/\/doi.org\/10.3390\/pharmaceutics16101327.","journal-title":"Pharmaceutics"},{"key":"3386_CR13","doi-asserted-by":"publisher","first-page":"114525","DOI":"10.1016\/j.ejpb.2024.114525","volume":"204","author":"K Hu","year":"2024","unstructured":"Hu K, Li X, Tan Z, Shi Y. Simple ROS-responsive micelles loaded Shikonin for efficient ovarian cancer targeting therapy by disrupting intracellular redox homeostasis. Eur J Pharm Biopharm. 2024;204:114525. https:\/\/doi.org\/10.1016\/j.ejpb.2024.114525.","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"3386_CR14","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3390\/nano11010070","volume":"11","author":"SM Tawfik","year":"2020","unstructured":"Tawfik SM, Azizov S, Elmasry MR, Sharipov M, Lee YI. Recent advances in nanomicelles delivery systems. Nanomaterials. 2020;11(1):70. https:\/\/doi.org\/10.3390\/nano11010070.","journal-title":"Nanomaterials"},{"key":"3386_CR15","doi-asserted-by":"publisher","unstructured":"Gao P, Wu Y, Yan Z. LncRNA ILF3-AS1 mediates oxidative stress and inflammation through miR\u2010504\u20103p\/HMGB1 axis in a cellular model of Temporal lobe epilepsy. Brain Behav. 2024;14(8). https:\/\/doi.org\/10.1002\/brb3.3615.","DOI":"10.1002\/brb3.3615"},{"key":"3386_CR16","doi-asserted-by":"publisher","unstructured":"Han Z, Zhao Z, Yu H, et al. Microenvironment-Responsive hydrogel reduces seizures after traumatic brain injury in juvenile rats by reducing oxidative stress and hippocampal inflammation. Macromol Biosci. 2024;24(8). https:\/\/doi.org\/10.1002\/mabi.202400050.","DOI":"10.1002\/mabi.202400050"},{"issue":"3","key":"3386_CR17","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.apsb.2022.09.019","volume":"13","author":"Z Zhou","year":"2023","unstructured":"Zhou Z, Li K, Chu Y, et al. ROS-removing nano-medicine for navigating inflammatory microenvironment to enhance anti-epileptic therapy. Acta Pharm Sinica B. 2023;13(3):1246\u201361. https:\/\/doi.org\/10.1016\/j.apsb.2022.09.019.","journal-title":"Acta Pharm Sinica B"},{"issue":"10","key":"3386_CR18","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.3390\/antiox12101877","volume":"12","author":"TA Patel","year":"2023","unstructured":"Patel TA, Kevadiya BD, Bajwa N, et al. Role of Nanoparticle-Conjugates and nanotheranostics in abrogating oxidative stress and ameliorating neuroinflammation. Antioxidants. 2023;12(10):1877. https:\/\/doi.org\/10.3390\/antiox12101877.","journal-title":"Antioxidants"},{"key":"3386_CR19","doi-asserted-by":"publisher","first-page":"106061","DOI":"10.1016\/j.tvjl.2023.106061","volume":"303","author":"SI Peek","year":"2024","unstructured":"Peek SI, Twele F, Meller S, Packer RMA, Volk HA. Epilepsy is more than a simple seizure disorder: causal relationships between epilepsy and its comorbidities. Vet J. 2024;303:106061. https:\/\/doi.org\/10.1016\/j.tvjl.2023.106061.","journal-title":"Vet J"},{"key":"3386_CR20","doi-asserted-by":"publisher","first-page":"119292","DOI":"10.1016\/j.biomaterials.2019.119292","volume":"217","author":"WC Ballance","year":"2019","unstructured":"Ballance WC, Qin EC, Chung HJ, Gillette MU, Kong H. Reactive oxygen species-responsive drug delivery systems for the treatment of neurodegenerative diseases. Biomaterials. 2019;217:119292. https:\/\/doi.org\/10.1016\/j.biomaterials.2019.119292.","journal-title":"Biomaterials"},{"key":"3386_CR21","doi-asserted-by":"publisher","unstructured":"Bonilla L, Esteruelas G, Ettcheto M, et al. Biodegradable nanoparticles for the treatment of epilepsy: from current advances to future challenges. Epilepsia Open. 2021;7(S1). https:\/\/doi.org\/10.1002\/epi4.12567.","DOI":"10.1002\/epi4.12567"},{"issue":"6","key":"3386_CR22","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1089\/ars.2017.7425","volume":"29","author":"CC Winterbourn","year":"2018","unstructured":"Winterbourn CC. Biological production, detection, and fate of hydrogen peroxide. Antioxid Redox Signal. 2018;29(6):541\u201351. https:\/\/doi.org\/10.1089\/ars.2017.7425.","journal-title":"Antioxid Redox Signal"},{"key":"3386_CR23","doi-asserted-by":"publisher","unstructured":"Mao XY, Zhou HH, Jin WL. Ferroptosis induction in Pentylenetetrazole kindling and Pilocarpine-Induced epileptic seizures in mice. Front Neurosci. 2019;13. https:\/\/doi.org\/10.3389\/fnins.2019.00721.","DOI":"10.3389\/fnins.2019.00721"},{"issue":"8","key":"3386_CR24","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1097\/wnr.0000000000001007","volume":"29","author":"K Pardo-Pe\u00f1a","year":"2018","unstructured":"Pardo-Pe\u00f1a K, S\u00e1nchez-Lira A, Salazar-S\u00e1nchez JC, Morales-Villagr\u00e1n A. A novel online fluorescence method for in-vivo measurement of hydrogen peroxide during oxidative stress produced in a Temporal lobe epilepsy model. NeuroReport. 2018;29(8):621\u201330. https:\/\/doi.org\/10.1097\/wnr.0000000000001007.","journal-title":"NeuroReport"},{"key":"3386_CR25","doi-asserted-by":"publisher","first-page":"116431","DOI":"10.1016\/j.neuroimage.2019.116431","volume":"208","author":"O Puonti","year":"2020","unstructured":"Puonti O, Saturnino GB, Madsen KH, Thielscher A. Value and limitations of intracranial recordings for validating electric field modeling for transcranial brain stimulation. NeuroImage. 2020;208:116431. https:\/\/doi.org\/10.1016\/j.neuroimage.2019.116431.","journal-title":"NeuroImage"},{"key":"3386_CR26","doi-asserted-by":"publisher","unstructured":"Drion CM, van Scheppingen J, Arena A, et al. Effects of Rapamycin and Curcumin on inflammation and oxidative stress in vitro and in vivo \u2014 in search of potential anti-epileptogenic strategies for Temporal lobe epilepsy. J Neuroinflammation. 2018;15(1). https:\/\/doi.org\/10.1186\/s12974-018-1247-9.","DOI":"10.1186\/s12974-018-1247-9"},{"issue":"8","key":"3386_CR27","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1007\/s10571-020-00826-1","volume":"40","author":"JF Sun","year":"2020","unstructured":"Sun JF, Zhao MY, Xu YJ, Su Y, Kong XH, Wang ZY. Fenamates inhibit human sodium channel Nav1.2 and protect Glutamate-Induced injury in SH-SY5Y cells. Cell Mol Neurobiol. 2020;40(8):1405\u201316. https:\/\/doi.org\/10.1007\/s10571-020-00826-1.","journal-title":"Cell Mol Neurobiol"},{"issue":"8","key":"3386_CR28","doi-asserted-by":"publisher","first-page":"4173","DOI":"10.1007\/s10571-023-01404-x","volume":"43","author":"F Burgio","year":"2023","unstructured":"Burgio F, Gaiser C, Brady K, et al. A perfused in vitro human iPSC-Derived Blood\u2013Brain barrier faithfully mimics transferrin Receptor-Mediated transcytosis of therapeutic antibodies. Cell Mol Neurobiol. 2023;43(8):4173\u201387. https:\/\/doi.org\/10.1007\/s10571-023-01404-x.","journal-title":"Cell Mol Neurobiol"},{"issue":"7","key":"3386_CR29","doi-asserted-by":"publisher","first-page":"3156","DOI":"10.1016\/j.apsb.2022.01.014","volume":"12","author":"T Ren","year":"2022","unstructured":"Ren T, Li R, Zhao L, Fawcett JP, Sun D, Gu J. Biological fate and interaction with cytochromes P450 of the nanocarrier material, d-\u03b1-tocopheryl polyethylene glycol 1000 succinate. Acta Pharm Sinica B. 2022;12(7):3156\u201366. https:\/\/doi.org\/10.1016\/j.apsb.2022.01.014.","journal-title":"Acta Pharm Sinica B"},{"key":"3386_CR30","doi-asserted-by":"publisher","unstructured":"Do\u01e7an E, Ayg\u00fcn H, Arslan G, et al. The role of NMDA receptors in the effect of purinergic P2X7 receptor on spontaneous seizure activity in WAG\/Rij rats with genetic absence epilepsy. Front Neurosci. 2020;14. https:\/\/doi.org\/10.3389\/fnins.2020.00414.","DOI":"10.3389\/fnins.2020.00414"},{"key":"3386_CR31","doi-asserted-by":"publisher","unstructured":"Huang C, Chi X sa, Li R et al. Inhibition of P2X7 Receptor Ameliorates Nuclear Factor-Kappa B Mediated Neuroinflammation Induced by Status Epilepticus in Rat Hippocampus. J Mol Neurosci. 2017;63(2):173\u2013184. https:\/\/doi.org\/10.1007\/s12031-017-0968-z","DOI":"10.1007\/s12031-017-0968-z"},{"issue":"8","key":"3386_CR32","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1111\/cns.13648","volume":"27","author":"H Cheng","year":"2021","unstructured":"Cheng H, Qi Y, Lai N, et al. Inhibition of hyperactivity of the dorsal Raphe 5-HTergic neurons ameliorates hippocampal seizure. CNS Neurosci Ther. 2021;27(8):963\u201372. https:\/\/doi.org\/10.1111\/cns.13648.","journal-title":"CNS Neurosci Ther"},{"issue":"2","key":"3386_CR33","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1007\/s13311-019-00815-3","volume":"17","author":"J Zhao","year":"2020","unstructured":"Zhao J, Zheng Y, Liu K, et al. HMGB1 is a therapeutic target and biomarker in Diazepam-Refractory status epilepticus with wide time window. Neurotherapeutics. 2020;17(2):710\u201321. https:\/\/doi.org\/10.1007\/s13311-019-00815-3.","journal-title":"Neurotherapeutics"},{"issue":"4","key":"3386_CR34","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1111\/j.1528-1167.2007.00980.x","volume":"48","author":"K Bethmann","year":"2007","unstructured":"Bethmann K, Brandt C, L\u00f6scher W. Resistance to phenobarbital extends to phenytoin in a rat model of Temporal lobe epilepsy. Epilepsia. 2007;48(4):816\u201326. https:\/\/doi.org\/10.1111\/j.1528-1167.2007.00980.x.","journal-title":"Epilepsia"},{"key":"3386_CR35","doi-asserted-by":"publisher","first-page":"119849","DOI":"10.1016\/j.biomaterials.2020.119849","volume":"240","author":"J Zhao","year":"2020","unstructured":"Zhao J, Ye Z, Yang J, et al. Nanocage encapsulation improves antiepileptic efficiency of phenytoin. Biomaterials. 2020;240:119849. https:\/\/doi.org\/10.1016\/j.biomaterials.2020.119849.","journal-title":"Biomaterials"},{"issue":"10","key":"3386_CR36","doi-asserted-by":"publisher","first-page":"5586","DOI":"10.3390\/ijms23105586","volume":"23","author":"X Zhang","year":"2022","unstructured":"Zhang X, Wang M, Feng B, et al. Seizures in PPT1 Knock-In mice are associated with inflammatory activation of microglia. IJMS. 2022;23(10):5586. https:\/\/doi.org\/10.3390\/ijms23105586.","journal-title":"IJMS"},{"key":"3386_CR37","doi-asserted-by":"publisher","unstructured":"Wu C, Zhang G, Chen L, et al. The role of NLRP3 and IL-1\u03b2 in refractory epilepsy brain injury. Front Neurol. 2020;10. https:\/\/doi.org\/10.3389\/fneur.2019.01418.","DOI":"10.3389\/fneur.2019.01418"},{"key":"3386_CR38","doi-asserted-by":"publisher","first-page":"106301","DOI":"10.1016\/j.eplepsyres.2020.106301","volume":"162","author":"RD Nass","year":"2020","unstructured":"Nass RD, Wagner M, Surges R, Holdenrieder S. Time courses of HMGB1 and other inflammatory markers after generalized convulsive seizures. Epilepsy Res. 2020;162:106301. https:\/\/doi.org\/10.1016\/j.eplepsyres.2020.106301.","journal-title":"Epilepsy Res"},{"issue":"1","key":"3386_CR39","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/jdn.10237","volume":"83","author":"W Yang","year":"2022","unstructured":"Yang W, Ma L, Xu S, et al. Gentiopicroside alleviated epileptogenesis in immature rats through inactivation of NLRP3 inflammasome by inhibiting P2X7R expression. Intl J Devlp Neurosci. 2022;83(1):53\u201366. https:\/\/doi.org\/10.1002\/jdn.10237.","journal-title":"Intl J Devlp Neurosci"},{"key":"3386_CR40","doi-asserted-by":"publisher","unstructured":"Al Noman A, Afrosa H, Lihu IK, et al. Vitamin D and neurological health: unraveling risk factors, disease progression, and treatment potential. CNSNDDT. 2024;24. https:\/\/doi.org\/10.2174\/0118715273330972241009092828.","DOI":"10.2174\/0118715273330972241009092828"},{"issue":"11","key":"3386_CR41","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.2174\/0118715273288155240201065041","volume":"23","author":"S Ashique","year":"2024","unstructured":"Ashique S, Pal R, Sharma H, Mishra N, Garg A. Unraveling the emerging niche role of extracellular vesicles (EVs) intraumatic brain injury (TBI). CNSNDDT. 2024;23(11):1357\u201370. https:\/\/doi.org\/10.2174\/0118715273288155240201065041.","journal-title":"CNSNDDT"},{"key":"3386_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2024.07.015","author":"T Li","year":"2024","unstructured":"Li T, Li Y, Chen J, et al. Hyperibone J exerts antidepressant effects by targeting ADK to inhibit microglial P2X7R\/TLR4-mediated neuroinflammation. J Adv Res Published Online July. 2024. https:\/\/doi.org\/10.1016\/j.jare.2024.07.015.","journal-title":"J Adv Res Published Online July"},{"issue":"3","key":"3386_CR43","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.immuni.2024.01.018","volume":"57","author":"S Huang","year":"2024","unstructured":"Huang S, Dong W, Lin X, et al. Disruption of the Na+\/K+-ATPase-purinergic P2X7 receptor complex in microglia promotes stress-induced anxiety. Immunity. 2024;57(3):495\u2013e51211. https:\/\/doi.org\/10.1016\/j.immuni.2024.01.018.","journal-title":"Immunity"},{"key":"3386_CR44","doi-asserted-by":"publisher","unstructured":"Das S, Mukherjee T, Mohanty S, et al. Impact of NF-\u03baB signaling and Sirtuin-1 protein for targetedinflammatory intervention. CPB. 2024;25. https:\/\/doi.org\/10.2174\/0113892010301469240409082212.","DOI":"10.2174\/0113892010301469240409082212"},{"issue":"2","key":"3386_CR45","doi-asserted-by":"publisher","first-page":"96","DOI":"10.2174\/0122115366287127240322054519","volume":"13","author":"H Sharma","year":"2024","unstructured":"Sharma H, Kaushik M, Goswami P, et al. Role of MiRNAs in brain development. MIRNA. 2024;13(2):96\u2013109. https:\/\/doi.org\/10.2174\/0122115366287127240322054519.","journal-title":"MIRNA"},{"issue":"4","key":"3386_CR46","doi-asserted-by":"publisher","first-page":"243","DOI":"10.2174\/0113894501339455241101065040","volume":"26","author":"A Inamdar","year":"2025","unstructured":"Inamdar A, Gurupadayya B, Halagali P, et al. Unraveling neurological drug delivery: polymeric nanocarriers for enhanced Blood-Brain barrier penetration. CDT. 2025;26(4):243\u201366. https:\/\/doi.org\/10.2174\/0113894501339455241101065040.","journal-title":"CDT"},{"issue":"8","key":"3386_CR47","doi-asserted-by":"publisher","first-page":"598","DOI":"10.2174\/0113816128344571241018154506","volume":"31","author":"A Inamdar","year":"2025","unstructured":"Inamdar A, Gurupadayya B, Halagali P, et al. Cutting-edge strategies for overcoming therapeutic barriers in Alzheimer\u2019s disease. CPD. 2025;31(8):598\u2013618. https:\/\/doi.org\/10.2174\/0113816128344571241018154506.","journal-title":"CPD"},{"key":"3386_CR48","doi-asserted-by":"publisher","unstructured":"Halagali P, Nayak D, Tippavajhala VK, Rathnanand M, Biswas D, Sharma H. Navigating the nanoscopic frontier: ethical dimensions in developing nanocarriers for neurodegenerative diseases. Neurodegeneration Revolution Published Online 2025:399\u2013420. https:\/\/doi.org\/10.1016\/b978-0-443-28822-7.00011-8","DOI":"10.1016\/b978-0-443-28822-7.00011-8"},{"key":"3386_CR49","doi-asserted-by":"publisher","unstructured":"Halagali P, Nayak D, Rathnanand M, Tippavajhala VK, Sharma H, Biswas D. Synergizing sustainable green nanotechnology and AI\/ML for advanced nanocarriers: A paradigm shift in the treatment of neurodegenerative diseases. Neurodegeneration Revolution Published Online 2025:373\u201397. https:\/\/doi.org\/10.1016\/b978-0-443-28822-7.00017-9","DOI":"10.1016\/b978-0-443-28822-7.00017-9"},{"key":"3386_CR50","doi-asserted-by":"publisher","unstructured":"Datta D, Colaco V, Bandi SP, Sharma H, Dhas N, Giram PS. Classes\/types of polymers used in oral delivery (natural, semisynthetic, synthetic), their chemical structure and general functionalities. Polymers for oral drug delivery technologies. Published Online 2025:263\u2013333. https:\/\/doi.org\/10.1016\/b978-0-443-13774-7.00007-4","DOI":"10.1016\/b978-0-443-13774-7.00007-4"},{"key":"3386_CR51","doi-asserted-by":"publisher","unstructured":"Kumar P, Sharma H, Singh A, Pandey SN, Chandra P. Correlation between exosomes and Neuro-inflammation in various brain disorders. Exosomes based drug delivery strategies for brain disorders. Published Online 2024:273\u2013302. https:\/\/doi.org\/10.1007\/978-981-99-8373-5_11","DOI":"10.1007\/978-981-99-8373-5_11"},{"key":"3386_CR52","doi-asserted-by":"publisher","unstructured":"Sharma H, Tyagi SJ, Chandra P et al. Role of exosomes in Parkinson\u2019s and Alzheimer\u2019s diseases. Exosomes based drug delivery strategies for brain disorders. Published Online 2024:147\u201382. https:\/\/doi.org\/10.1007\/978-981-99-8373-5_6","DOI":"10.1007\/978-981-99-8373-5_6"},{"key":"3386_CR53","doi-asserted-by":"publisher","unstructured":"Sharma H, Rachamalla HK, Mishra N, Chandra P, Pathak R, Ashique S. Introduction to exosome and its role in brain disorders. Exosomes based drug delivery strategies for brain disorders. Published Online 2024:1\u201335. https:\/\/doi.org\/10.1007\/978-981-99-8373-5_1","DOI":"10.1007\/978-981-99-8373-5_1"},{"key":"3386_CR54","doi-asserted-by":"publisher","first-page":"155146","DOI":"10.1016\/j.prp.2024.155146","volume":"254","author":"SS Abdel Mageed","year":"2024","unstructured":"Abdel Mageed SS, Rashad AA, Elshaer SS, et al. The emerging role of MiRNAs in epilepsy: from molecular signatures to diagnostic potential. Pathol - Res Pract. 2024;254:155146. https:\/\/doi.org\/10.1016\/j.prp.2024.155146.","journal-title":"Pathol - Res Pract"},{"key":"3386_CR55","doi-asserted-by":"publisher","unstructured":"Al Noman A, Dev Sharma P, Jahin Mim T, Al Azad M, Sharma H. Molecular Docking and ADMET analysis of coenzyme Q10 as a potential therapeutic agent for Alzheimer\u2019s disease. APT. 2024;6(4). https:\/\/doi.org\/10.31491\/apt.2024.12.155.","DOI":"10.31491\/apt.2024.12.155"},{"issue":"1","key":"3386_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12035-024-04220-6","volume":"62","author":"M Dhureja","year":"2024","unstructured":"Dhureja M, Chaturvedi P, Choudhary A, Kumar P, Munshi A. Molecular insights of drug resistance in epilepsy: Multi-omics unveil. Mol Neurobiol. 2024;62(1):1\u201317. https:\/\/doi.org\/10.1007\/s12035-024-04220-6.","journal-title":"Mol Neurobiol"},{"key":"3386_CR57","doi-asserted-by":"publisher","unstructured":"Sarkar S, Bhui U, Kumar B, et al. Correlation between cognitive impairment and peripheral Biomarkers - Significance of phosphorylated Tau and Amyloid-\u03b2 in Alzheimer\u2019s disease: A new insight. CPRR. 2024;21. https:\/\/doi.org\/10.2174\/0126660822329981241007105405.","DOI":"10.2174\/0126660822329981241007105405"},{"issue":"07","key":"3386_CR58","doi-asserted-by":"publisher","first-page":"7","DOI":"10.53879\/id.61.07.14382","volume":"61","author":"P Chandra","year":"2024","unstructured":"Chandra P, Sharma H, PHOSPHODIESTERASE INHIBITORS FOR TREATMENT OF ALZHEIMER\u2019S, DISEASE. IND DRU. 2024;61(07):7\u201322. https:\/\/doi.org\/10.53879\/id.61.07.14382.","journal-title":"IND DRU"},{"key":"3386_CR59","doi-asserted-by":"publisher","unstructured":"Sharma H, Pathak R, Biswas D. Unveiling the therapeutic potential of modern probiotics in addressing neurodegenerative disorders: A comprehensive exploration, review and future perspectives on intervention strategies. CPRR. 2024;20. https:\/\/doi.org\/10.2174\/0126660822304321240520075036.","DOI":"10.2174\/0126660822304321240520075036"},{"key":"3386_CR60","doi-asserted-by":"publisher","unstructured":"Chandra P, Ali Z, Fatima N, et al. Shankhpushpi (Convolvulus pluricaulis): exploring its cognitive enhancing mechanisms and therapeutic potential in neurodegenerative disorders. CBC. 2025;21(2). https:\/\/doi.org\/10.2174\/0115734072292339240416095600.","DOI":"10.2174\/0115734072292339240416095600"},{"issue":"1","key":"3386_CR61","doi-asserted-by":"publisher","first-page":"117","DOI":"10.5530\/ijpi.14.1.15","volume":"14","author":"H Sharma","year":"2023","unstructured":"Sharma H, Chandra P, Challenges, Prospects F. A benefaction of phytoconstituents on molecular targets pertaining to Alzheimer\u2019s disease. Int J Pharm Invest. 2023;14(1):117\u201326. https:\/\/doi.org\/10.5530\/ijpi.14.1.15.","journal-title":"Int J Pharm Invest"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03386-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03386-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03386-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T16:03:37Z","timestamp":1746461017000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-025-03386-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,5]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3386"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03386-y","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,5]]},"assertion":[{"value":"22 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved by the Animal Ethics Committee of Renmin Hospital of Wuhan University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"332"}}